ARTICLE | Top Story
EC approves Ilaris for gouty arthritis
March 2, 2013 1:40 AM UTC
The European Commission approved a label expansion for Ilaris canakinumab from Novartis AG (NYSE:NVS; SIX:NOVN) to include treatment of gouty arthritis. Ilaris is approved to treat adults with frequen...